CASR and familial hypocalciuric hypercalcemia: Taken together, the novel D99N homozygous mutation in the CaSR gene reduces CaSR activity, leading to reduced sensitivity of parathyroid cells to extracellular Ca2+ and abnormal PTH secretion, thereby causing more severe hypocalciuric hypercalcemia.